Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Nepeta menthoides* Boiss. & Buhse is a medicinal plant in the Lamiaceae family, native to Iran, where it is traditionally known as Ustukhuddus-e-Nuri in Persian medicine. It is primarily utilized for its sedative, anxiolytic, and antidepressant properties. Clinical research, notably conducted by the Shiraz University of Medical Sciences, has evaluated freeze-dried extracts of the plant in randomized controlled trials for the treatment of anxiety and depression, often comparing its efficacy to standard pharmaceuticals like sertraline. The plant's pharmacological activity is attributed to various secondary metabolites, including nepetalactones and flavonoids, which are thought to modulate the GABAergic system to produce calming effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nepeta menthoides boiss. & buhse.